lorazepam glucuronide has been researched along with Kidney Failure, Chronic in 1 studies
*Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Schepper, PJ; Tjandramaga, TB; Verbeeck, R; Verberckmoes, R | 1 |
1 trial(s) available for lorazepam glucuronide and Kidney Failure, Chronic
| Article | Year |
|---|---|
Biotransformation and excretion of lorazepam in patients with chronic renal failure.
Topics: Adult; Anti-Anxiety Agents; Biotransformation; Humans; Kidney Failure, Chronic; Lorazepam; Male; Renal Dialysis; Young Adult | 1976 |